<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: SGNT News</title><copyright>Copyright (c) 2013 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=sgnt</link><description>Latest Financial News for Sagent Pharmaceuticals, Inc.</description><language>en-US</language><lastBuildDate>Sun, 12 May 2013 07:54:41 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Finance: SGNT News</title><link>http://finance.yahoo.com/q/h?s=sgnt</link><width>144</width><height>45</height></image><item><title>China Biotech In Review: Sagent Buys Out China JV Partner For $25 Million</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13hq1q0oo/*http://seekingalpha.com/article/1427531-china-biotech-in-review-sagent-buys-out-china-jv-partner-for-25-million?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/1538893314</guid><pubDate>Sun, 12 May 2013 07:54:41 GMT</pubDate></item><item><title>SAGENT PHARMACEUTICALS, INC. Financials</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=sgnt</link><description></description><guid isPermaLink="false">yahoo_finance/4089583164</guid><pubDate>Sat, 11 May 2013 17:04:33 GMT</pubDate></item><item><title>Q1 2013 SAGENT Pharmaceuticals Inc Earnings Release - Before Market Open</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20130506.html?t=sgnt</link><description></description><guid isPermaLink="false">yahoo_finance/899376905</guid><pubDate>Mon, 06 May 2013 11:07:06 GMT</pubDate></item><item><title>Sagent Pharmaceuticals Reports First Quarter 2013 Financial Results</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/sagent-pharmaceuticals-reports-first-quarter-110000687.html</link><description>[GlobeNewswire] - SCHAUMBURG, Ill. -- Sagent Pharmaceuticals, Inc. , a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced financial results for the quarter ended March ...</description><guid isPermaLink="false">yahoo_finance/695647101</guid><pubDate>Mon, 06 May 2013 11:00:00 GMT</pubDate></item><item><title>Sagent Pharmaceuticals Announces Agreement to Acquire Remaining 50% Interest in Chinese Manufacturing Joint Venture</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/sagent-pharmaceuticals-announces-agreement-acquire-110000386.html</link><description>[GlobeNewswire] - SCHAUMBURG, Ill. -- Sagent Pharmaceuticals, Inc. , a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced an agreement to acquire the 50% interest of its ...</description><guid isPermaLink="false">yahoo_finance/990911472</guid><pubDate>Mon, 06 May 2013 11:00:00 GMT</pubDate></item><item><title>SAGENT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations an</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130506/sgnt8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/537094765</guid><pubDate>Mon, 06 May 2013 05:01:54 GMT</pubDate></item><item><title>Wall Street Transcript Interview with David Amsellem, Managing Director and Senior Research Analyst at Piper Jaffray &amp; Co.: Alternative Dosage Forms Create Barriers Against Competition in Generics</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/wall-street-transcript-interview-david-150700719.html</link><description></description><guid isPermaLink="false">yahoo_finance/170688951</guid><pubDate>Thu, 02 May 2013 15:07:00 GMT</pubDate></item><item><title>Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2013 Financial Results</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/sagent-pharmaceuticals-sets-date-time-120000027.html</link><description>[GlobeNewswire] - SCHAUMBURG, Ill. -- Sagent Pharmaceuticals, Inc. , a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that it will release financial results for the ...</description><guid isPermaLink="false">yahoo_finance/643937527</guid><pubDate>Wed, 24 Apr 2013 12:00:00 GMT</pubDate></item><item><title>3 Biggest Biotech Crashes This Month</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12s6ekt8r/*http://www.fool.com/investing/general/2013/03/31/3-biggest-biotech-crashes-this-month.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3148721235</guid><pubDate>Sun, 31 Mar 2013 17:30:00 GMT</pubDate></item><item><title>Follow The Crashing Biotechs: 4 Stocks Fresh From A Fall</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=131ed90c7/*http://seekingalpha.com/article/1290071-follow-the-crashing-biotechs-4-stocks-fresh-from-a-fall?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/1592015289</guid><pubDate>Wed, 20 Mar 2013 19:03:51 GMT</pubDate></item><item><title>SAGENT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial S</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130320/sgnt8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2392041163</guid><pubDate>Wed, 20 Mar 2013 03:03:48 GMT</pubDate></item><item><title>Sagent Pharmaceuticals Appoints James M. Hussey as President</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125lo41tp/*http://www.noodls.com/view/5FCAFE06458B58356617DC8B9F06246234164942</link><description>[at noodls] - SCHAUMBURG, Ill., March 19, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced ...</description><guid isPermaLink="false">yahoo_finance/3636707856</guid><pubDate>Tue, 19 Mar 2013 22:51:50 GMT</pubDate></item><item><title>Sagent Pharmaceuticals Appoints James M. Hussey as President</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/sagent-pharmaceuticals-appoints-james-m-213620956.html</link><description>[GlobeNewswire] - SCHAUMBURG, Ill. -- Sagent Pharmaceuticals, Inc. , a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that its Board of Directors has appointed James ...</description><guid isPermaLink="false">yahoo_finance/3413801140</guid><pubDate>Tue, 19 Mar 2013 21:36:20 GMT</pubDate></item><item><title>SAGENT PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130318/sgnt10-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3232174243</guid><pubDate>Mon, 18 Mar 2013 13:32:20 GMT</pubDate></item><item><title>This Week in Biotech</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12f25l4jc/*http://www.fool.com/investing/general/2013/03/16/this-week-in-biotech-19.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2318681040</guid><pubDate>Sat, 16 Mar 2013 16:00:00 GMT</pubDate></item><item><title>Picking Up the Pieces of Shattered Spectrum</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=133u4it0b/*http://www.fool.com/investing/general/2013/03/14/picking-up-the-pieces-of-shattered-spectrum.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3549831825</guid><pubDate>Thu, 14 Mar 2013 22:33:00 GMT</pubDate></item><item><title>Has Spectrum Pharmaceuticals Become the Perfect Stock?</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13a39o7vh/*http://www.fool.com/investing/general/2013/03/14/has-spectrum-pharmaceuticals-become-the-perfect-st.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2921358110</guid><pubDate>Thu, 14 Mar 2013 14:36:00 GMT</pubDate></item><item><title>Spectrum shares plunge as hospitals switch to cheaper colon cancer treatment</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=12kpdadno/*http://www.reuters.com/article/2013/03/13/us-spectrum-shares-idUSBRE92C0YU20130313?feedType=RSS&amp;feedName=globalMarketsNews&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/3381756913</guid><pubDate>Wed, 13 Mar 2013 17:44:17 GMT</pubDate></item><item><title>Spectrum Pharma Stock Plunges After Guidance Whacked</title><link>http://us.rd.yahoo.com/finance/external/investors/rss/SIG=12v1enmt9/*http://news.investors.com/article/647820/031313/spectrum-stock-falls-after-2013-sales-cut.htm?ven=yahoocp&amp;ven=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/691662469</guid><pubDate>Wed, 13 Mar 2013 14:50:00 GMT</pubDate></item><item><title>Down 35%! This Is a Biotech Trainwreck</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12suiv9rc/*http://www.fool.com/investing/general/2013/03/13/down-35-this-is-a-biotech-trainwreck.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/1712776324</guid><pubDate>Wed, 13 Mar 2013 14:06:00 GMT</pubDate></item></channel></rss>